Table of Content

1 INTRODUCTION (Page No. - 30)
    1.1 STUDY OBJECTIVES 
    1.2 MARKET DEFINITION 
    1.3 MARKET SCOPE 
           1.3.1 MARKETS COVERED
           1.3.2 INCLUSIONS & EXCLUSIONS
           1.3.3 YEARS CONSIDERED
           1.3.4 CURRENCY CONSIDERED
    1.4 STAKEHOLDERS 
    1.5 SUMMARY OF CHANGES 
2 RESEARCH METHODOLOGY (Page No. - 35)
    2.1 RESEARCH DATA 
           2.1.1 SECONDARY DATA
                    2.1.1.1 Key data from secondary sources
           2.1.2 PRIMARY DATA
                    2.1.2.1 Key data from primary sources
                    2.1.2.2 Key industry insights
    2.2 MARKET SIZE ESTIMATION 
    2.3 MARKET BREAKDOWN & DATA TRIANGULATION 
    2.4 MARKET SHARE ESTIMATION 
    2.5 ASSUMPTIONS 
    2.6 RISK ASSESSMENT 
    2.7 RESEARCH LIMITATIONS 
3 EXECUTIVE SUMMARY (Page No. - 48)
4 PREMIUM INSIGHTS (Page No. - 54)
    4.1 NON-INVASIVE PRENATAL TESTING MARKET OVERVIEW 
    4.2 EUROPE: NON-INVASIVE PRENATAL TESTING MARKET, BY APPLICATION 
    4.3 GEOGRAPHIC MIX: NON-INVASIVE PRENATAL TESTING MARKET, 2024–2029 (USD MILLION) 
    4.4 NON-INVASIVE PRENATAL TESTING MARKET: EMERGING ECONOMIES VS. DEVELOPED MARKETS, 2024 VS. 2029 
5 MARKET OVERVIEW (Page No. - 57)
    5.1 INTRODUCTION 
    5.2 MARKET DYNAMICS 
           5.2.1 DRIVERS
                    5.2.1.1 High risk of chromosomal abnormalities with increasing maternal age
                    5.2.1.2 Growing preference for noninvasive techniques over invasive methods
                    5.2.1.3 Improving reimbursement scenario
                    5.2.1.4 Initiatives to spread awareness
           5.2.2 RESTRAINTS
                    5.2.2.1 High cost of procedures
                    5.2.2.2 Lack of insurance coverage
           5.2.3 OPPORTUNITIES
                    5.2.3.1 Untapped emerging markets
                    5.2.3.2 Technological advancements
           5.2.4 CHALLENGES
                    5.2.4.1 Reliability of test results
                    5.2.4.2 Lack of skilled professionals
    5.3 INDUSTRY TRENDS 
           5.3.1 DETECTION BEYOND TRISOMIES
           5.3.2 EARLIER GESTATIONAL AGE TESTING
           5.3.3 INTEGRATION WITH NGS
    5.4 TECHNOLOGY ANALYSIS 
           5.4.1 KEY TECHNOLOGIES
                    5.4.1.1 Cell-free DNA analysis
                    5.4.1.2 NGS
                    5.4.1.3 Digital PCR
           5.4.2 COMPLEMENTARY TECHNOLOGIES
                    5.4.2.1 Microfluidics
                    5.4.2.2 Nanotechnology
                    5.4.2.3 Epigenetics analysis
           5.4.3 ADJACENT TECHNOLOGIES
                    5.4.3.1 Ultrasound imaging
                    5.4.3.2 Genome editing (CRISPR/Cas9)
                    5.4.3.3 Liquid biopsy
    5.5 VALUE CHAIN ANALYSIS 
    5.6 ECOSYSTEM ANALYSIS 
    5.7 SUPPLY CHAIN ANALYSIS 
    5.8 PORTER’S FIVE FORCE ANALYSIS 
           5.8.1 THREAT OF NEW ENTRANTS
           5.8.2 THREAT OF SUBSTITUTES
           5.8.3 BARGAINING POWER OF SUPPLIERS
           5.8.4 BARGAINING POWER OF BUYERS
           5.8.5 INTENSITY OF COMPETITIVE RIVALRY
    5.9 KEY STAKEHOLDERS AND BUYING CRITERIA 
           5.9.1 KEY STAKEHOLDERS IN BUYING PROCESS
           5.9.2 BUYING CRITERIA
    5.10 REGULATORY LANDSCAPE 
           5.10.1 REGULATORY ANALYSIS
           5.10.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    5.11 PATENT ANALYSIS 
           5.11.1 PATENT PUBLICATION TRENDS
           5.11.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS
    5.12 TRADE ANALYSIS 
           5.12.1 TRADE ANALYSIS FOR DIAGNOSTIC AND LABORATORY REAGENTS
    5.13 PRICING ANALYSIS 
           5.13.1 AVERAGE SELLING PRICE TREND, BY PRODUCT
           5.13.2 AVERAGE SELLING PRICE TREND, BY REGION
    5.14 REIMBURSEMENT ANALYSIS 
    5.15 KEY CONFERENCES AND EVENTS, 2024–2025 
    5.16 UNMET NEEDS/END-USER EXPECTATIONS 
    5.17 CASE STUDIES 
           5.17.1 EVALUATION OF NIFTY TEST IN DETECTING FETAL CHROMOSOMAL ABNORMALITIES IN ASIAN POPULATIONS
           5.17.2 CLINICAL UTILITY OF HARMONY PRENATAL TEST IN A COHORT OF PREGNANT WOMEN
           5.17.3 ASSESSMENT OF PANORAMA TEST IN DETECTING FETAL GENETIC CONDITIONS
    5.18 ADJACENT MARKET ANALYSIS 
    5.19 INVESTMENT & FUNDING SCENARIO 
    5.20 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 
    5.21 IMPACT OF ARTIFICIAL INTELLIGENCE ON NON-INVASIVE PRENATAL TESTING MARKET 
6 NON-INVASIVE PRENATAL TESTING MARKET, BY PRODUCT & SERVICE (Page No. - 93)
    6.1 INTRODUCTION 
    6.2 PRODUCTS 
           6.2.1 CONSUMABLES
                    6.2.1.1 Assay kits & reagents
                               6.2.1.1.1 Frequent use of reagents and assay kits to drive market
                    6.2.1.2 Disposables
                               6.2.1.2.1 Need for contamination-free workflow to boost demand for disposables
           6.2.2 INSTRUMENTS
                    6.2.2.1 Ultrasound devices
                               6.2.2.1.1 Popularity of ultrasound in fetal and embryonic imaging and safety to drive market
                    6.2.2.2 NGS systems
                               6.2.2.2.1 Rising use of NGS in NIPT to drive market
                    6.2.2.3 PCR instruments
                               6.2.2.3.1 Increasing research in prenatal genetic testing to boost market growth
                    6.2.2.4 Microarrays
                               6.2.2.4.1 Flexibility of chips and short processing times to support usage
                    6.2.2.5 Other instruments
    6.3 SERVICES 
           6.3.1 NORTH AMERICA TO REGISTER HIGHEST DEMAND FOR TESTING SERVICES
7 NON-INVASIVE PRENATAL TESTING MARKET, BY METHOD (Page No. - 120)
    7.1 INTRODUCTION 
    7.2 ULTRASOUND DETECTION 
           7.2.1 ULTRASOUND DETECTION TO DOMINATE NIPT MARKET
    7.3 BIOCHEMICAL SCREENING TESTS 
           7.3.1 HIGH INCIDENCE OF GENETIC DISORDERS AND INCREASING FOCUS ON PRENATAL TESTING TO SUPPORT MARKET GROWTH
    7.4 CFDNA IN MATERNAL PLASMA TESTS 
           7.4.1 CFDNA IN MATERNAL PLASMA TESTS SEGMENT TO REGISTER HIGHEST CAGR
8 NON-INVASIVE PRENATAL TESTING MARKET, BY APPLICATION (Page No. - 129)
    8.1 INTRODUCTION 
    8.2 TRISOMY 
           8.2.1 TRISOMY TO HOLD LARGEST SHARE OF APPLICATIONS MARKET AND SHOW HIGHEST GROWTH
    8.3 MICRODELETION SYNDROME 
           8.3.1 INCREASING AWARENESS TO SUPPORT DEMAND FOR TESTING
    8.4 OTHER APPLICATIONS 
9 NON-INVASIVE PRENATAL TESTING MARKET, BY END USER (Page No. - 138)
    9.1 INTRODUCTION 
    9.2 DIAGNOSTIC LABORATORIES 
           9.2.1 RISING RESEARCH INTENSITY TO DRIVE USAGE OF NIPT PRODUCTS IN DIAGNOSTIC LABS
    9.3 HOSPITALS 
           9.3.1 RISING INCIDENCE OF GENETIC DISORDERS AND INCREASING FOCUS ON PRENATAL TESTING TO PROPEL MARKET
10 NON-INVASIVE PRENATAL TESTING MARKET, BY REGION (Page No. - 144)
     10.1 INTRODUCTION 
     10.2 NORTH AMERICA 
             10.2.1 NORTH AMERICA: MACROECONOMIC OUTLOOK
             10.2.2 US
                        10.2.2.1 High incidence of chromosomal syndromes to drive demand
             10.2.3 CANADA
                        10.2.3.1 Unfavorable reimbursement scenario for NIPT to challenge market growth
     10.3 EUROPE 
             10.3.1 EUROPE: MACROECONOMIC OUTLOOK
             10.3.2 UK
                        10.3.2.1 High incidence of genetic abnormalities to increase demand for prenatal testing
             10.3.3 GERMANY
                        10.3.3.1 Strong R&D and increasing healthcare spending to drive market
             10.3.4 FRANCE
                        10.3.4.1 Favorable insurance coverage for prenatal testing to increase adoption of NIPT
             10.3.5 ITALY
                        10.3.5.1 Favorable funding scenario for genomics to drive market
             10.3.6 SPAIN
                        10.3.6.1 Rising funding and expanding research infrastructure to propel market growth
             10.3.7 REST OF EUROPE
     10.4 ASIA PACIFIC 
             10.4.1 ASIA PACIFIC: MACROECONOMIC OUTLOOK
             10.4.2 JAPAN
                        10.4.2.1 Rising maternal age to propel incidence of chromosomal disorders
             10.4.3 CHINA
                        10.4.3.1 China to register highest growth in Asia Pacific market
             10.4.4 INDIA
                        10.4.4.1 Rising disposable income and demand for better health to support market growth
             10.4.5 AUSTRALIA
                        10.4.5.1 Strong research ecosystem for NIPT to drive market
             10.4.6 SOUTH KOREA
                        10.4.6.1 Increasing scope for genomic research to support market growth
             10.4.7 REST OF ASIA PACIFIC
     10.5 LATIN AMERICA 
             10.5.1 LATIN AMERICA: MACROECONOMIC OUTLOOK
             10.5.2 BRAZIL
                        10.5.2.1 Rising focus on clinical genomics to drive demand for NIPT
             10.5.3 MEXICO
                        10.5.3.1 High incidence of Down syndrome to propel demand
             10.5.4 REST OF LATIN AMERICA
     10.6 MIDDLE EAST & AFRICA 
             10.6.1 MIDDLE EAST & AFRICA: MACROECONOMIC OUTLOOK
             10.6.2 GCC COUNTRIES
                        10.6.2.1 Launch of genomic initiatives to drive market
             10.6.3 REST OF MIDDLE EAST & AFRICA
11 COMPETITIVE LANDSCAPE (Page No. - 280)
     11.1 OVERVIEW 
     11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 
             11.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN NON-INVASIVE PRENATAL TESTING MARKET
     11.3 REVENUE ANALYSIS 
     11.4 MARKET SHARE ANALYSIS 
     11.5 R&D EXPENDITURE OF KEY PLAYERS 
     11.6 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023 
             11.6.1 STARS
             11.6.2 EMERGING LEADERS
             11.6.3 PERVASIVE PLAYERS
             11.6.4 PARTICIPANTS
             11.6.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
                        11.6.5.1 Company footprint
                        11.6.5.2 Product & service footprint
                        11.6.5.3 Method footprint
                        11.6.5.4 Application footprint
                        11.6.5.5 End-user footprint
                        11.6.5.6 Region footprint
     11.7 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023 
             11.7.1 PROGRESSIVE COMPANIES
             11.7.2 DYNAMIC COMPANIES
             11.7.3 STARTING BLOCKS
             11.7.4 RESPONSIVE COMPANIES
             11.7.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
     11.8 VALUATION & FINANCIAL METRICS 
     11.9 BRAND/PRODUCT COMPARATIVE ANALYSIS 
     11.10 COMPETITIVE SCENARIO 
             11.10.1 PRODUCT & SERVICE LAUNCHES
             11.10.2 DEALS
             11.10.3 EXPANSIONS
             11.10.4 OTHER DEVELOPMENTS
12 COMPANY PROFILES (Page No. - 301)
     12.1 KEY PLAYERS 
             12.1.1 ILLUMINA, INC.
                        12.1.1.1 Business overview
                        12.1.1.2 Products & services offered
                        12.1.1.3 Recent developments
                                     12.1.1.3.1 Product launches & approvals
                                     12.1.1.3.2 Expansions
                                     12.1.1.3.3 Other developments
                        12.1.1.4 MnM view
                                     12.1.1.4.1 Key strengths
                                     12.1.1.4.2 Strategic choices
                                     12.1.1.4.3 Weaknesses & competitive threats
             12.1.2 NATERA, INC.
                        12.1.2.1 Business overview
                        12.1.2.2 Products & services offered
                        12.1.2.3 Recent developments
                                     12.1.2.3.1 Product & service launches and approvals
                                     12.1.2.3.2 Deals
                        12.1.2.4 MnM view
                                     12.1.2.4.1 Key strengths
                                     12.1.2.4.2 Strategic choices
                                     12.1.2.4.3 Weaknesses & competitive threats
             12.1.3 LABORATORY CORPORATION OF AMERICA HOLDINGS
                        12.1.3.1 Business overview
                        12.1.3.2 Products & services offered
                        12.1.3.3 Recent developments
                                     12.1.3.3.1 Deals
                        12.1.3.4 MnM view
                                     12.1.3.4.1 Key strengths
                                     12.1.3.4.2 Strategic choices
                                     12.1.3.4.3 Weaknesses & competitive threats
             12.1.4 EUROFINS SCIENTIFIC
                        12.1.4.1 Business overview
                        12.1.4.2 Products & services offered
                        12.1.4.3 Recent developments
                                     12.1.4.3.1 Service launches
                                     12.1.4.3.2 Deals
                        12.1.4.4 MnM view
                                     12.1.4.4.1 Key strengths
                                     12.1.4.4.2 Strategic choices
                                     12.1.4.4.3 Weaknesses & competitive threats
             12.1.5 F. HOFFMANN-LA ROCHE AG
                        12.1.5.1 Business overview
                        12.1.5.2 Products & services offered
                        12.1.5.3 Recent developments
                                     12.1.5.3.1 Product launches
                                     12.1.5.3.2 Deals
                        12.1.5.4 MnM view
                                     12.1.5.4.1 Key strengths
                                     12.1.5.4.2 Strategic choices
                                     12.1.5.4.3 Weaknesses & competitive threats
             12.1.6 REVVITY, INC.
                        12.1.6.1 Business overview
                        12.1.6.2 Products & services offered
                        12.1.6.3 Recent developments
                                     12.1.6.3.1 Product launches
                                     12.1.6.3.2 Deals
             12.1.7 THERMO FISHER SCIENTIFIC INC.
                        12.1.7.1 Business overview
                        12.1.7.2 Products & services offered
                        12.1.7.3 Recent developments
                                     12.1.7.3.1 Deals
             12.1.8 AGILENT TECHNOLOGIES
                        12.1.8.1 Business overview
                        12.1.8.2 Products & services offered
                        12.1.8.3 Recent developments
                                     12.1.8.3.1 Deals
             12.1.9 GE HEALTHCARE TECHNOLOGIES INC.
                        12.1.9.1 Business overview
                        12.1.9.2 Products & services offered
                        12.1.9.3 Recent developments
                                     12.1.9.3.1 Product & service launches and approvals
                                     12.1.9.3.2 Expansions
             12.1.10 QUEST DIAGNOSTICS INCORPORATED
                        12.1.10.1 Business overview
                        12.1.10.2 Products & services offered
                        12.1.10.3 Recent developments
                                     12.1.10.3.1 Product launches
                                     12.1.10.3.2 Deals
             12.1.11 SONIC HEALTHCARE LIMITED
                        12.1.11.1 Business overview
                        12.1.11.2 Products & services offered
                        12.1.11.3 Recent developments
                                     12.1.11.3.1 Deals
                                     12.1.11.3.2 Expansions
             12.1.12 CENTOGENE N.V.
                        12.1.12.1 Business overview
                        12.1.12.2 Products & services offered
                        12.1.12.3 Recent developments
                                     12.1.12.3.1 Product launches
                                     12.1.12.3.2 Deals
                                     12.1.12.3.3 Other developments
             12.1.13 QIAGEN N.V.
                        12.1.13.1 Business overview
                        12.1.13.2 Products & services offered
                        12.1.13.3 Recent developments
                                     12.1.13.3.1 Product launches
                                     12.1.13.3.2 Deals
                                     12.1.13.3.3 Expansions
             12.1.14 PATHWEST LABORATORY MEDICINE WA
                        12.1.14.1 Business overview
                        12.1.14.2 Products & services offered
             12.1.15 MYRIAD GENETICS, INC.
                        12.1.15.1 Business overview
                        12.1.15.2 Products & services offered
     12.2 OTHER PLAYERS 
             12.2.1 BGI GENOMICS CO., LTD.
             12.2.2 OXFORD NANOPORE TECHNOLOGIES PLC
             12.2.3 MEDGENOME
             12.2.4 NEUBERG DIAGNOSTICS
             12.2.5 ANNOROAD GENE TECHNOLOGY
             12.2.6 NEXT BIOSCIENCES
             12.2.7 LILAC INSIGHTS
             12.2.8 INVITAE CORPORATION
             12.2.9 BAYLOR GENETICS
             12.2.10 RAVGEN
13 APPENDIX (Page No. - 361)
     13.1 DISCUSSION GUIDE 
     13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 
     13.3 CUSTOMIZATION OPTIONS 
     13.4 RELATED REPORTS 
     13.5 AUTHOR DETAILS 


List of Figures

FIGURE 1 NIPT MARKET SEGMENTATION 31
FIGURE 2 NIPT MARKET: RESEARCH DESIGN 35
FIGURE 3 PRIMARY SOURCES 38
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE):
BY COMPANY TYPE, DESIGNATION, AND REGION 40
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE):
BY END USER, DESIGNATION, AND REGION 40
FIGURE 6 MARKET SIZE APPROACH: REVENUE SHARE ANALYSIS 41
FIGURE 7 TOP-DOWN APPROACH 42
FIGURE 8 BOTTOM-UP APPROACH 42
FIGURE 9 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS OPPORTUNITIES, AND CHALLENGES 44
FIGURE 10 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 45
FIGURE 11 DATA TRIANGULATION METHODOLOGY 46
FIGURE 12 SERVICES SEGMENT TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD 48
FIGURE 13 CONSUMABLES TO HOLD LARGEST SHARE OF PRODUCTS MARKET 49
FIGURE 14 DISPOSABLES SEGMENT TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD 49
FIGURE 15 NGS SYSTEMS TO REGISTER HIGHEST GROWTH IN INSTRUMENTS MARKET 50
FIGURE 16 ULTRASOUND DETECTION SEGMENT TO HOLD LARGEST MARKET SHARE 50
FIGURE 17 TRISOMY TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD 51
FIGURE 18 DIAGNOSTIC LABORATORIES TO DOMINATE END-USER MARKET 52
FIGURE 19 NORTH AMERICA AND EUROPE ACCOUNTED FOR LARGEST
MARKET SHARES IN 2023 53
FIGURE 20 HIGH RISK OF CHROMOSOMAL ABNORMALITIES WITH INCREASING MATERNAL AGE TO DRIVE ADOPTION 54
FIGURE 21 TRISOMY HELD LARGEST SHARE OF EUROPEAN MARKET IN 2023 55
FIGURE 22 ASIA PACIFIC TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD 56
FIGURE 23 EMERGING ECONOMIES TO REGISTER HIGHER GROWTH DURING
THE FORECAST PERIOD 56
FIGURE 24 NIPT MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 57
FIGURE 25 INTEGRATION WITH NGS?A LEADING TREND IN NIPT 63
FIGURE 26 VALUE CHAIN ANALYSIS OF NIPT MARKET: R&D AND MANUFACTURING PHASE ADD MAXIMUM VALUE 69
FIGURE 27 NIPT MARKET: ECOSYSTEM 70
FIGURE 28 NIPT MARKET: SUPPLY CHAIN ANALYSIS 72
FIGURE 29 NIPT MARKET: PORTER’S FIVE FORCES ANALYSIS 73
FIGURE 30 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF NIPT PRODUCTS 75
FIGURE 31 KEY BUYING CRITERIA FOR NIPT PRODUCTS 76
FIGURE 32 GLOBAL NUMBER OF PATENT PUBLICATIONS (JANUARY 2014?JUNE 2024) 80
FIGURE 33 TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR NIPT PATENTS (JANUARY 2014? JUNE 2024) 81
?
FIGURE 34 TOP APPLICANT COUNTRIES/REGIONS FOR NIPT (JANUARY 2014? JUNE 2024) 82
FIGURE 35 OVERVIEW OF ADJACENT MARKETS TO NIPT 90
FIGURE 36 NIPT MARKET: INVESTMENT & FUNDING SCENARIO (2019–2023) 91
FIGURE 37 REVENUE SHIFTS IN NIPT MARKET 92
FIGURE 38 NIPT MARKET: GEOGRAPHIC SNAPSHOT 145
FIGURE 39 NORTH AMERICA: NIPT MARKET SNAPSHOT 148
FIGURE 40 ASIA PACIFIC: NON-INVASIVE PRENATAL TESTING MARKET SNAPSHOT 204
FIGURE 41 REVENUE ANALYSIS OF TOP PLAYERS IN NIPT MARKET (2021–2023) 282
FIGURE 42 MARKET SHARE ANALYSIS OF KEY PLAYERS IN NIPT MARKET (2023) 283
FIGURE 43 R&D EXPENDITURE OF KEY PLAYERS IN NIPT, 2021–2023 285
FIGURE 44 NIPT MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023 286
FIGURE 45 NIPT MARKET: COMPANY FOOTPRINT 287
FIGURE 46 NIPT MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023 294
FIGURE 47 EV/EBITDA OF KEY PLAYERS 296
FIGURE 48 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF
KEY VENDORS 297
FIGURE 49 ILLUMINA: COMPANY SNAPSHOT (2023) 302
FIGURE 50 NATERA: COMPANY SNAPSHOT (2023) 307
FIGURE 51 LABORATORY CORPORATION OF AMERICA HOLDINGS:
COMPANY SNAPSHOT (2023) 311
FIGURE 52 EUROFINS SCIENTIFIC: COMPANY SNAPSHOT (2023) 315
FIGURE 53 F. HOFFMANN-LA ROCHE: COMPANY SNAPSHOT (2023) 319
FIGURE 54 REVVITY: COMPANY SNAPSHOT (2023) 323
FIGURE 55 THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT (2023) 327
FIGURE 56 AGILENT TECHNOLOGIES: COMPANY SNAPSHOT (2023) 330
FIGURE 57 GE HEALTHCARE: COMPANY SNAPSHOT (2023) 333
FIGURE 58 QUEST DIAGNOSTICS: COMPANY SNAPSHOT (2023) 335
FIGURE 59 SONIC HEALTHCARE: COMPANY SNAPSHOT (2023) 339
FIGURE 60 CENTOGENE: COMPANY SNAPSHOT (2023) 342
FIGURE 61 QIAGEN: COMPANY SNAPSHOT (2023) 345
FIGURE 62 PATHWEST LABORATORY MEDICINE: COMPANY SNAPSHOT (2023) 348
FIGURE 63 MYRIAD GENETICS: COMPANY SNAPSHOT (2023) 351

List of Tables

TABLE 1 STANDARD CURRENCY CONVERSION RATES (UNIT OF USD) 33
TABLE 2 RISK OF DOWN SYNDROME WITH INCREASING MATERNAL AGE 58
TABLE 3 INCIDENCE RATE OF TRISOMY 59
TABLE 4 COMPARISON OF NONINVASIVE AND INVASIVE PRENATAL TESTING 59
TABLE 5 NIPT REIMBURSEMENT SCENARIO, BY COUNTRY 60
TABLE 6 PUBLIC HEALTHCARE EXPENDITURE (% OF GDP) 61
TABLE 7 NIPT MARKET: ECOSYSTEM ANALYSIS 70
TABLE 8 NIPT MARKET: PORTER’S FIVE FORCES ANALYSIS 72
TABLE 9 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF NIPT PRODUCTS 75
TABLE 10 KEY BUYING CRITERIA FOR NIPT PRODUCTS 76
TABLE 11 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES AND OTHER ORGANIZATIONS 78
TABLE 12 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES AND OTHER ORGANIZATIONS 78
TABLE 13 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES AND OTHER ORGANIZATIONS 79
TABLE 14 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES AND OTHER ORGANIZATIONS 79
TABLE 15 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES AND OTHER ORGANIZATIONS 80
TABLE 16 LIST OF PATENTS IN NIPT MARKET, 2014–2024 82
TABLE 17 IMPORT AND EXPORT DATA FOR NEXT-GENERATION SEQUENCING PRODUCTS BY COUNTRY 84
TABLE 18 AVERAGE SELLING PRICE TREND OF NIPT PRODUCTS, BY TYPE 85
TABLE 19 AVERAGE SELLING PRICE TREND OF NIPT PRODUCTS, BY REGION 85
TABLE 20 NIPT MARKET: LIST OF KEY CONFERENCES AND EVENTS DURING 2024–2025 87
TABLE 21 NIPT MARKET: UNMET NEEDS 88
TABLE 22 NIPT MARKET: END-USER EXPECTATIONS 88
TABLE 23 NIPT MARKET: IMPACT AND APPLICATIONS OF ARTIFICIAL INTELLIGENCE 92
TABLE 24 NIPT MARKET, BY PRODUCT & SERVICE, 2021–2023 (USD MILLION) 94
TABLE 25 NIPT MARKET, BY PRODUCT & SERVICE, 2024–2029 (USD MILLION) 94
TABLE 26 NIPT PRODUCTS MARKET, BY TYPE, 2021–2023 (USD MILLION) 95
TABLE 27 NIPT PRODUCTS MARKET, BY TYPE, 2024–2029 (USD MILLION) 95
TABLE 28 NIPT PRODUCTS MARKET, BY COUNTRY, 2021–2023 (USD MILLION) 96
TABLE 29 NIPT PRODUCTS MARKET, BY COUNTRY, 2024–2029 (USD MILLION) 97
TABLE 30 NIPT CONSUMABLES MARKET, BY TYPE, 2021–2023 (USD MILLION) 98
TABLE 31 NIPT CONSUMABLES MARKET, BY TYPE, 2024–2029 (USD MILLION) 98
TABLE 32 NIPT CONSUMABLES MARKET, BY COUNTRY, 2021–2023 (USD MILLION) 99
TABLE 33 NIPT CONSUMABLES MARKET, BY COUNTRY, 2024–2029 (USD MILLION) 100
TABLE 34 ASSAY KITS & REAGENTS MARKET, BY COUNTRY, 2021–2023 (USD MILLION) 101
TABLE 35 ASSAY KITS & REAGENTS MARKET, BY COUNTRY, 2024–2029 (USD MILLION) 102
TABLE 36 DISPOSABLES MARKET, BY COUNTRY, 2021–2023 (USD MILLION) 103
TABLE 37 DISPOSABLES MARKET, BY COUNTRY, 2024–2029 (USD MILLION) 104
TABLE 38 NIPT INSTRUMENTS MARKET, BY TYPE, 2021–2023 (USD MILLION) 105
TABLE 39 NIPT INSTRUMENTS MARKET, BY TYPE, 2024–2029 (USD MILLION) 105
TABLE 40 NIPT INSTRUMENTS MARKET, BY COUNTRY, 2021–2023 (USD MILLION) 106
TABLE 41 NIPT INSTRUMENTS MARKET, BY COUNTRY, 2024–2029 (USD MILLION) 107
TABLE 42 ULTRASOUND DEVICES MARKET, BY COUNTRY, 2021–2023 (USD MILLION) 108
TABLE 43 ULTRASOUND DEVICES MARKET, BY COUNTRY, 2024–2029 (USD MILLION) 109
TABLE 44 NGS SYSTEMS MARKET, BY COUNTRY, 2021–2023 (USD MILLION) 110
TABLE 45 NGS SYSTEMS MARKET, BY COUNTRY, 2024–2029 (USD MILLION) 111
TABLE 46 PCR INSTRUMENTS MARKET, BY COUNTRY, 2021–2023 (USD MILLION) 112
TABLE 47 PCR INSTRUMENTS MARKET, BY COUNTRY, 2024–2029 (USD MILLION) 113
TABLE 48 MICROARRAYS MARKET, BY COUNTRY, 2021–2023 (USD MILLION) 114
TABLE 49 MICROARRAYS MARKET, BY COUNTRY, 2024–2029 (USD MILLION) 115
TABLE 50 OTHER NIPT INSTRUMENTS MARKET, BY COUNTRY, 2021–2023 (USD MILLION) 116
TABLE 51 OTHER NIPT INSTRUMENTS MARKET, BY COUNTRY, 2024–2029 (USD MILLION) 117
TABLE 52 NIPT SERVICES MARKET, BY COUNTRY, 2021–2023 (USD MILLION) 118
TABLE 53 NIPT SERVICES MARKET, BY COUNTRY, 2024–2029 (USD MILLION) 119
TABLE 54 NIPT MARKET, BY METHOD, 2021–2023 (USD MILLION) 121
TABLE 55 NIPT MARKET, BY METHOD, 2024–2029 (USD MILLION) 121
TABLE 56 ULTRASOUND DETECTION MARKET, BY COUNTRY, 2021–2023 (USD MILLION) 122
TABLE 57 ULTRASOUND DETECTION MARKET, BY COUNTRY, 2024–2029 (USD MILLION) 123
TABLE 58 BIOCHEMICAL SCREENING TESTS MARKET, BY COUNTRY 2021–2023 (USD MILLION) 125
TABLE 59 BIOCHEMICAL SCREENING TESTS MARKET, BY COUNTRY 2024–2029 (USD MILLION) 126
TABLE 60 CFDNA IN MATERNAL PLASMA TESTS MARKET, BY COUNTRY 2021–2023 (USD MILLION) 127
TABLE 61 CFDNA IN MATERNAL PLASMA TESTS MARKET, BY COUNTRY 2024–2029 (USD MILLION) 128
TABLE 62 NIPT MARKET, BY APPLICATION, 2021–2023 (USD MILLION) 130
TABLE 63 NIPT MARKET, BY APPLICATION, 2024–2029 (USD MILLION) 130
TABLE 64 NIPT MARKET FOR TRISOMY, BY COUNTRY, 2021–2023 (USD MILLION) 132
TABLE 65 NIPT MARKET FOR TRISOMY, BY COUNTRY, 2024–2029 (USD MILLION) 133
TABLE 66 NIPT MARKET FOR MICRODELETION SYNDROME BY COUNTRY, 2021–2023 (USD MILLION) 134
TABLE 67 NIPT MARKET FOR MICRODELETION SYNDROME BY COUNTRY, 2024–2029 (USD MILLION) 135
TABLE 68 NIPT MARKET FOR OTHER APPLICATIONS BY COUNTRY, 2021–2023 (USD MILLION) 136
TABLE 69 NIPT MARKET FOR OTHER APPLICATIONS BY COUNTRY, 2024–2029 (USD MILLION) 137
TABLE 70 NIPT MARKET, BY END USER, 2021–2023 (USD MILLION) 139
TABLE 71 NIPT MARKET, BY END USER, 2024–2029 (USD MILLION) 139
TABLE 72 NIPT MARKET FOR DIAGNOSTIC LABORATORIES BY COUNTRY, 2021–2023 (USD MILLION) 140
TABLE 73 NIPT MARKET FOR DIAGNOSTIC LABORATORIES BY COUNTRY, 2024–2029 (USD MILLION) 141
TABLE 74 NIPT MARKET FOR HOSPITALS, BY COUNTRY, 2021–2023 (USD MILLION) 142
TABLE 75 NIPT MARKET FOR HOSPITALS, BY COUNTRY, 2024–2029 (USD MILLION) 143
TABLE 76 NIPT MARKET, BY REGION, 2021–2023 (USD MILLION) 146
TABLE 77 NIPT MARKET, BY REGION, 2024–2029 (USD MILLION) 146
TABLE 78 NORTH AMERICA: NIPT MARKET, BY COUNTRY, 2021–2023 (USD MILLION) 148
TABLE 79 NORTH AMERICA: NIPT MARKET, BY COUNTRY, 2024–2029 (USD MILLION) 149
TABLE 80 NORTH AMERICA: NIPT MARKET, BY PRODUCT & SERVICE 2021–2023 (USD MILLION) 149
TABLE 81 NORTH AMERICA: NIPT MARKET, BY PRODUCT & SERVICE 2024–2029 (USD MILLION) 149
TABLE 82 NORTH AMERICA: NIPT PRODUCTS MARKET, BY TYPE, 2021–2023 (USD MILLION) 150
TABLE 83 NORTH AMERICA: NIPT PRODUCTS MARKET, BY TYPE, 2024–2029 (USD MILLION) 150
TABLE 84 NORTH AMERICA: NIPT CONSUMABLES MARKET BY TYPE, 2021–2023 (USD MILLION) 150
TABLE 85 NORTH AMERICA: NIPT CONSUMABLES MARKET BY TYPE, 2024–2029 (USD MILLION) 151
TABLE 86 NORTH AMERICA: NIPT INSTRUMENTS MARKET BY TYPE, 2021–2023 (USD MILLION) 151
TABLE 87 NORTH AMERICA: NIPT INSTRUMENTS MARKET BY TYPE, 2024–2029 (USD MILLION) 151
TABLE 88 NORTH AMERICA: NIPT MARKET, BY METHOD, 2021–2023 (USD MILLION) 152
TABLE 89 NORTH AMERICA: NIPT MARKET, BY METHOD, 2024–2029 (USD MILLION) 152
TABLE 90 NORTH AMERICA: NIPT MARKET, BY APPLICATION, 2021–2023 (USD MILLION) 152
TABLE 91 NORTH AMERICA: NIPT MARKET, BY APPLICATION, 2024–2029 (USD MILLION) 153
TABLE 92 NORTH AMERICA: NIPT MARKET, BY END USER, 2021–2023 (USD MILLION) 153
TABLE 93 NORTH AMERICA: NIPT MARKET, BY END USER, 2024–2029 (USD MILLION) 153
TABLE 94 US: KEY MACROINDICATORS 154
TABLE 95 US: NIPT MARKET, BY PRODUCT & SERVICE, 2021–2023 (USD MILLION) 154
TABLE 96 US: NIPT MARKET, BY PRODUCT & SERVICE, 2024–2029 (USD MILLION) 155
TABLE 97 US: NIPT PRODUCTS MARKET, BY TYPE, 2021–2023 (USD MILLION) 155
TABLE 98 US: NIPT PRODUCTS MARKET, BY TYPE, 2024–2029 (USD MILLION) 155
TABLE 99 US: NIPT CONSUMABLES MARKET, BY TYPE, 2021–2023 (USD MILLION) 156
TABLE 100 US: NIPT CONSUMABLES MARKET, BY TYPE, 2024–2029 (USD MILLION) 156
TABLE 101 US: NIPT INSTRUMENTS MARKET, BY TYPE, 2021–2023 (USD MILLION) 156
TABLE 102 US: NIPT INSTRUMENTS MARKET, BY TYPE, 2024–2029 (USD MILLION) 157
TABLE 103 US: NIPT MARKET, BY METHOD, 2021–2023 (USD MILLION) 157
TABLE 104 US: NIPT MARKET, BY METHOD, 2024–2029 (USD MILLION) 157
TABLE 105 US: NIPT MARKET, BY APPLICATION, 2021–2023 (USD MILLION) 158
TABLE 106 US: NIPT MARKET, BY APPLICATION, 2024–2029 (USD MILLION) 158
TABLE 107 US: NIPT MARKET, BY END USER, 2021–2023 (USD MILLION) 158
TABLE 108 US: NIPT MARKET, BY END USER, 2024–2029 (USD MILLION) 159
TABLE 109 CANADA: KEY MACROINDICATORS 159
TABLE 110 CANADA: NIPT MARKET, BY PRODUCT & SERVICE, 2021–2023 (USD MILLION) 160
TABLE 111 CANADA: NIPT MARKET, BY PRODUCT & SERVICE, 2024–2029 (USD MILLION) 160
TABLE 112 CANADA: NIPT PRODUCTS MARKET, BY TYPE, 2021–2023 (USD MILLION) 160
TABLE 113 CANADA: NIPT PRODUCTS MARKET, BY TYPE, 2024–2029 (USD MILLION) 161
TABLE 114 CANADA: NIPT CONSUMABLES MARKET, BY TYPE, 2021–2023 (USD MILLION) 161
TABLE 115 CANADA: NIPT CONSUMABLES MARKET, BY TYPE, 2024–2029 (USD MILLION) 161
TABLE 116 CANADA: NIPT INSTRUMENTS MARKET, BY TYPE, 2021–2023 (USD MILLION) 162
TABLE 117 CANADA: NIPT INSTRUMENTS MARKET, BY TYPE, 2024–2029 (USD MILLION) 162
TABLE 118 CANADA: NIPT MARKET, BY METHOD, 2021–2023 (USD MILLION) 162
TABLE 119 CANADA: NIPT MARKET, BY METHOD, 2024–2029 (USD MILLION) 163
TABLE 120 CANADA: NIPT MARKET, BY APPLICATION, 2021–2023 (USD MILLION) 163
TABLE 121 CANADA: NIPT MARKET, BY APPLICATION, 2024–2029 (USD MILLION) 163
TABLE 122 CANADA: NIPT MARKET, BY END USER, 2021–2023 (USD MILLION) 164
TABLE 123 CANADA: NIPT MARKET, BY END USER, 2024–2029 (USD MILLION) 164
TABLE 124 EUROPE: NIPT MARKET, BY COUNTRY, 2021–2023 (USD MILLION) 165
TABLE 125 EUROPE: NIPT MARKET, BY COUNTRY, 2024–2029 (USD MILLION) 166
TABLE 126 EUROPE: NIPT MARKET, BY PRODUCT & SERVICE, 2021–2023 (USD MILLION) 166
TABLE 127 EUROPE: NIPT MARKET, BY PRODUCT & SERVICE, 2024–2029 (USD MILLION) 166
TABLE 128 EUROPE: NIPT PRODUCTS MARKET, BY TYPE, 2021–2023 (USD MILLION) 167
TABLE 129 EUROPE: NIPT PRODUCTS MARKET, BY TYPE, 2024–2029 (USD MILLION) 167
TABLE 130 EUROPE: NIPT CONSUMABLES MARKET, BY TYPE, 2021–2023 (USD MILLION) 167
TABLE 131 EUROPE: NIPT CONSUMABLES MARKET, BY TYPE, 2024–2029 (USD MILLION) 168
TABLE 132 EUROPE: NIPT INSTRUMENTS MARKET, BY TYPE, 2021–2023 (USD MILLION) 168
TABLE 133 EUROPE: NIPT INSTRUMENTS MARKET, BY TYPE, 2024–2029 (USD MILLION) 168
TABLE 134 EUROPE: NIPT MARKET, BY METHOD, 2021–2023 (USD MILLION) 169
TABLE 135 EUROPE: NIPT MARKET, BY METHOD, 2024–2029 (USD MILLION) 169
TABLE 136 EUROPE: NIPT MARKET, BY APPLICATION, 2021–2023 (USD MILLION) 169
TABLE 137 EUROPE: NIPT MARKET, BY APPLICATION, 2024–2029 (USD MILLION) 170
TABLE 138 EUROPE: NIPT MARKET, BY END USER, 2021–2023 (USD MILLION) 170
TABLE 139 EUROPE: NIPT MARKET, BY END USER, 2024–2029 (USD MILLION) 170
TABLE 140 UK: KEY MACROINDICATORS 171
TABLE 141 UK: NIPT MARKET, BY PRODUCT & SERVICE, 2021–2023 (USD MILLION) 171
TABLE 142 UK: NIPT MARKET, BY PRODUCT & SERVICE, 2024–2029 (USD MILLION) 172
TABLE 143 UK: NIPT PRODUCTS MARKET, BY TYPE, 2021–2023 (USD MILLION) 172
TABLE 144 UK: NIPT PRODUCTS MARKET, BY TYPE, 2024–2029 (USD MILLION) 172
TABLE 145 UK: NIPT CONSUMABLES MARKET, BY TYPE, 2021–2023 (USD MILLION) 173
TABLE 146 UK: NIPT CONSUMABLES MARKET, BY TYPE, 2024–2029 (USD MILLION) 173
TABLE 147 UK: NIPT INSTRUMENTS MARKET, BY TYPE, 2021–2023 (USD MILLION) 173
TABLE 148 UK: NIPT INSTRUMENTS MARKET, BY TYPE, 2024–2029 (USD MILLION) 174
TABLE 149 UK: NIPT MARKET, BY METHOD, 2021–2023 (USD MILLION) 174
TABLE 150 UK: NIPT MARKET, BY METHOD, 2024–2029 (USD MILLION) 174
TABLE 151 UK: NIPT MARKET, BY APPLICATION, 2021–2023 (USD MILLION) 175
TABLE 152 UK: NIPT MARKET, BY APPLICATION, 2024–2029 (USD MILLION) 175
TABLE 153 UK: NIPT MARKET, BY END USER, 2021–2023 (USD MILLION) 175
TABLE 154 UK: NIPT MARKET, BY END USER, 2024–2029 (USD MILLION) 176
TABLE 155 GERMANY: KEY MACROINDICATORS 177
TABLE 156 GERMANY: NIPT MARKET, BY PRODUCT & SERVICE, 2021–2023 (USD MILLION) 177
TABLE 157 GERMANY: NIPT MARKET, BY PRODUCT & SERVICE, 2024–2029 (USD MILLION) 177
TABLE 158 GERMANY: NIPT PRODUCTS MARKET, BY TYPE, 2021–2023 (USD MILLION) 178
TABLE 159 GERMANY: NIPT PRODUCTS MARKET, BY TYPE, 2024–2029 (USD MILLION) 178
TABLE 160 GERMANY: NIPT CONSUMABLES MARKET, BY TYPE, 2021–2023 (USD MILLION) 178
TABLE 161 GERMANY: NIPT CONSUMABLES MARKET, BY TYPE, 2024–2029 (USD MILLION) 179
TABLE 162 GERMANY: NIPT INSTRUMENTS MARKET, BY TYPE, 2021–2023 (USD MILLION) 179
TABLE 163 GERMANY: NIPT INSTRUMENTS MARKET, BY TYPE, 2024–2029 (USD MILLION) 179
TABLE 164 GERMANY: NIPT MARKET, BY METHOD, 2021–2023 (USD MILLION) 180
TABLE 165 GERMANY: NIPT MARKET, BY METHOD, 2024–2029 (USD MILLION) 180
TABLE 166 GERMANY: NIPT MARKET, BY APPLICATION, 2021–2023 (USD MILLION) 180
TABLE 167 GERMANY: NIPT MARKET, BY APPLICATION, 2024–2029 (USD MILLION) 181
TABLE 168 GERMANY: NIPT MARKET, BY END USER, 2021–2023 (USD MILLION) 181
TABLE 169 GERMANY: NIPT MARKET, BY END USER, 2024–2029 (USD MILLION) 181
TABLE 170 FRANCE: KEY MACROINDICATORS 182
TABLE 171 FRANCE: NIPT MARKET, BY PRODUCT & SERVICE, 2021–2023 (USD MILLION) 182
TABLE 172 FRANCE: NIPT MARKET, BY PRODUCT & SERVICE, 2024–2029 (USD MILLION) 183
TABLE 173 FRANCE: NIPT PRODUCTS MARKET, BY TYPE, 2021–2023 (USD MILLION) 183
TABLE 174 FRANCE: NIPT PRODUCTS MARKET, BY TYPE, 2024–2029 (USD MILLION) 183
TABLE 175 FRANCE: NIPT CONSUMABLES MARKET, BY TYPE, 2021–2023 (USD MILLION) 184
TABLE 176 FRANCE: NIPT CONSUMABLES MARKET, BY TYPE, 2024–2029 (USD MILLION) 184
TABLE 177 FRANCE: NIPT INSTRUMENTS MARKET, BY TYPE, 2021–2023 (USD MILLION) 184
TABLE 178 FRANCE: NIPT INSTRUMENTS MARKET, BY TYPE, 2024–2029 (USD MILLION) 185
TABLE 179 FRANCE: NIPT MARKET, BY METHOD, 2021–2023 (USD MILLION) 185
TABLE 180 FRANCE: NIPT MARKET, BY METHOD, 2024–2029 (USD MILLION) 185
TABLE 181 FRANCE: NIPT MARKET, BY APPLICATION, 2021–2023 (USD MILLION) 186
TABLE 182 FRANCE: NIPT MARKET, BY APPLICATION, 2024–2029 (USD MILLION) 186
TABLE 183 FRANCE: NIPT MARKET, BY END USER, 2021–2023 (USD MILLION) 186
TABLE 184 FRANCE: NIPT MARKET, BY END USER, 2024–2029 (USD MILLION) 187
TABLE 185 ITALY: KEY MACROINDICATORS 187
TABLE 186 ITALY: NIPT MARKET, BY PRODUCT & SERVICE, 2021–2023 (USD MILLION) 188
TABLE 187 ITALY: NIPT MARKET, BY PRODUCT & SERVICE, 2024–2029 (USD MILLION) 188
TABLE 188 ITALY: NIPT PRODUCTS MARKET, BY TYPE, 2021–2023 (USD MILLION) 188
TABLE 189 ITALY: NIPT PRODUCTS MARKET, BY TYPE, 2024–2029 (USD MILLION) 189
TABLE 190 ITALY: NIPT CONSUMABLES MARKET, BY TYPE, 2021–2023 (USD MILLION) 189
TABLE 191 ITALY: NIPT CONSUMABLES MARKET, BY TYPE, 2024–2029 (USD MILLION) 189
TABLE 192 ITALY: NIPT INSTRUMENTS MARKET, BY TYPE, 2021–2023 (USD MILLION) 190
TABLE 193 ITALY: NIPT INSTRUMENTS MARKET, BY TYPE, 2024–2029 (USD MILLION) 190
TABLE 194 ITALY: NIPT MARKET, BY METHOD, 2021–2023 (USD MILLION) 190
TABLE 195 ITALY: NIPT MARKET, BY METHOD, 2024–2029 (USD MILLION) 191
TABLE 196 ITALY: NIPT MARKET, BY APPLICATION, 2021–2023 (USD MILLION) 191
TABLE 197 ITALY: NIPT MARKET, BY APPLICATION, 2024–2029 (USD MILLION) 191
TABLE 198 ITALY: NIPT MARKET, BY END USER, 2021–2023 (USD MILLION) 192
TABLE 199 ITALY: NIPT MARKET, BY END USER, 2024–2029 (USD MILLION) 192
TABLE 200 SPAIN: KEY MACROINDICATORS 193
TABLE 201 SPAIN: NIPT MARKET, BY PRODUCT & SERVICE, 2021–2023 (USD MILLION) 193
TABLE 202 SPAIN: NIPT MARKET, BY PRODUCT & SERVICE, 2024–2029 (USD MILLION) 193
TABLE 203 SPAIN: NIPT PRODUCTS MARKET, BY TYPE, 2021–2023 (USD MILLION) 194
TABLE 204 SPAIN: NIPT PRODUCTS MARKET, BY TYPE, 2024–2029 (USD MILLION) 194
TABLE 205 SPAIN: NIPT CONSUMABLES MARKET, BY TYPE, 2021–2023 (USD MILLION) 194
TABLE 206 SPAIN: NIPT CONSUMABLES MARKET, BY TYPE, 2024–2029 (USD MILLION) 195
TABLE 207 SPAIN: NIPT INSTRUMENTS MARKET, BY TYPE, 2021–2023 (USD MILLION) 195
TABLE 208 SPAIN: NIPT INSTRUMENTS MARKET, BY TYPE, 2024–2029 (USD MILLION) 195
TABLE 209 SPAIN: NIPT MARKET, BY METHOD, 2021–2023 (USD MILLION) 196
TABLE 210 SPAIN: NIPT MARKET, BY METHOD, 2024–2029 (USD MILLION) 196
TABLE 211 SPAIN: NIPT MARKET, BY APPLICATION, 2021–2023 (USD MILLION) 196
TABLE 212 SPAIN: NIPT MARKET, BY APPLICATION, 2024–2029 (USD MILLION) 197
TABLE 213 SPAIN: NIPT MARKET, BY END USER, 2021–2023 (USD MILLION) 197
TABLE 214 SPAIN: NIPT MARKET, BY END USER, 2024–2029 (USD MILLION) 197
TABLE 215 REST OF EUROPE: NIPT MARKET, BY PRODUCT & SERVICE 2021–2023 (USD MILLION) 198
TABLE 216 REST OF EUROPE: NIPT MARKET, BY PRODUCT & SERVICE 2024–2029 (USD MILLION) 198
TABLE 217 REST OF EUROPE: NIPT PRODUCTS MARKET, BY TYPE, 2021–2023 (USD MILLION) 199
TABLE 218 REST OF EUROPE: NIPT PRODUCTS MARKET, BY TYPE, 2024–2029 (USD MILLION) 199
TABLE 219 REST OF EUROPE: NIPT CONSUMABLES MARKET BY TYPE, 2021–2023 (USD MILLION) 199
TABLE 220 REST OF EUROPE: NIPT CONSUMABLES MARKET BY TYPE, 2024–2029 (USD MILLION) 200
TABLE 221 REST OF EUROPE: NIPT INSTRUMENTS MARKET BY TYPE, 2021–2023 (USD MILLION) 200
TABLE 222 REST OF EUROPE: NIPT INSTRUMENTS MARKET BY TYPE, 2024–2029 (USD MILLION) 200
TABLE 223 REST OF EUROPE: NIPT MARKET, BY METHOD, 2021–2023 (USD MILLION) 201
TABLE 224 REST OF EUROPE: NIPT MARKET, BY METHOD, 2024–2029 (USD MILLION) 201
TABLE 225 REST OF EUROPE: NIPT MARKET, BY APPLICATION, 2021–2023 (USD MILLION) 201
TABLE 226 REST OF EUROPE: NIPT MARKET, BY APPLICATION, 2024–2029 (USD MILLION) 202
TABLE 227 REST OF EUROPE: NIPT MARKET, BY END USER, 2021–2023 (USD MILLION) 202
TABLE 228 REST OF EUROPE: NIPT MARKET, BY END USER, 2024–2029 (USD MILLION) 202
TABLE 229 ASIA PACIFIC: NIPT MARKET, BY COUNTRY, 2021–2023 (USD MILLION) 205
TABLE 230 ASIA PACIFIC: NIPT MARKET, BY COUNTRY, 2024–2029 (USD MILLION) 205
TABLE 231 ASIA PACIFIC: NIPT MARKET, BY PRODUCT & SERVICE, 2021–2023 (USD MILLION) 205
TABLE 232 ASIA PACIFIC: NIPT MARKET, BY PRODUCT & SERVICE, 2024–2029 (USD MILLION) 206
TABLE 233 ASIA PACIFIC: NIPT PRODUCTS MARKET, BY TYPE, 2021–2023 (USD MILLION) 206
TABLE 234 ASIA PACIFIC: NIPT PRODUCTS MARKET, BY TYPE, 2024–2029 (USD MILLION) 206
TABLE 235 ASIA PACIFIC: NIPT CONSUMABLES MARKET, BY TYPE, 2021–2023 (USD MILLION) 207
TABLE 236 ASIA PACIFIC: NIPT CONSUMABLES MARKET, BY TYPE, 2024–2029 (USD MILLION) 207
TABLE 237 ASIA PACIFIC: NIPT INSTRUMENTS MARKET, BY TYPE, 2021–2023 (USD MILLION) 207
TABLE 238 ASIA PACIFIC: NIPT INSTRUMENTS MARKET, BY TYPE, 2024–2029 (USD MILLION) 208
TABLE 239 ASIA PACIFIC: NIPT MARKET, BY METHOD, 2021–2023 (USD MILLION) 208
TABLE 240 ASIA PACIFIC: NIPT MARKET, BY METHOD, 2024–2029 (USD MILLION) 208
TABLE 241 ASIA PACIFIC: NIPT MARKET, BY APPLICATION, 2021–2023 (USD MILLION) 209
TABLE 242 ASIA PACIFIC: NIPT MARKET, BY APPLICATION, 2024–2029 (USD MILLION) 209
TABLE 243 ASIA PACIFIC: NIPT MARKET, BY END USER, 2021–2023 (USD MILLION) 209
TABLE 244 ASIA PACIFIC: NIPT MARKET, BY END USER, 2024–2029 (USD MILLION) 210
TABLE 245 JAPAN: KEY MACROINDICATORS 210
TABLE 246 JAPAN: NIPT MARKET, BY PRODUCT & SERVICE, 2021–2023 (USD MILLION) 211
TABLE 247 JAPAN: NIPT MARKET, BY PRODUCT & SERVICE, 2024–2029 (USD MILLION) 211
TABLE 248 JAPAN: NIPT PRODUCTS MARKET, BY TYPE, 2021–2023 (USD MILLION) 211
TABLE 249 JAPAN: NIPT PRODUCTS MARKET, BY TYPE, 2024–2029 (USD MILLION) 212
TABLE 250 JAPAN: NIPT CONSUMABLES MARKET, BY TYPE, 2021–2023 (USD MILLION) 212
TABLE 251 JAPAN: NIPT CONSUMABLES MARKET, BY TYPE, 2024–2029 (USD MILLION) 212
TABLE 252 JAPAN: NIPT INSTRUMENTS MARKET, BY TYPE, 2021–2023 (USD MILLION) 213
TABLE 253 JAPAN: NIPT INSTRUMENTS MARKET, BY TYPE, 2024–2029 (USD MILLION) 213
TABLE 254 JAPAN: NIPT MARKET, BY METHOD, 2021–2023 (USD MILLION) 213
TABLE 255 JAPAN: NIPT MARKET, BY METHOD, 2024–2029 (USD MILLION) 214
TABLE 256 JAPAN: NIPT MARKET, BY APPLICATION, 2021–2023 (USD MILLION) 214
TABLE 257 JAPAN: NIPT MARKET, BY APPLICATION, 2024–2029 (USD MILLION) 214
TABLE 258 JAPAN: NIPT MARKET, BY END USER, 2021–2023 (USD MILLION) 215
TABLE 259 JAPAN: NIPT MARKET, BY END USER, 2024–2029 (USD MILLION) 215
TABLE 260 CHINA: KEY MACROINDICATORS 216
TABLE 261 CHINA: NIPT MARKET, BY PRODUCT & SERVICE, 2021–2023 (USD MILLION) 216
TABLE 262 CHINA: NIPT MARKET, BY PRODUCT & SERVICE, 2024–2029 (USD MILLION) 216
TABLE 263 CHINA: NIPT PRODUCTS MARKET, BY TYPE, 2021–2023 (USD MILLION) 217
TABLE 264 CHINA: NIPT PRODUCTS MARKET, BY TYPE, 2024–2029 (USD MILLION) 217
TABLE 265 CHINA: NIPT CONSUMABLES MARKET, BY TYPE, 2021–2023 (USD MILLION) 217
TABLE 266 CHINA: NIPT CONSUMABLES MARKET, BY TYPE, 2024–2029 (USD MILLION) 218
TABLE 267 CHINA: NIPT INSTRUMENTS MARKET, BY TYPE, 2021–2023 (USD MILLION) 218
TABLE 268 CHINA: NIPT INSTRUMENTS MARKET, BY TYPE, 2024–2029 (USD MILLION) 218
TABLE 269 CHINA: NIPT MARKET, BY METHOD, 2021–2023 (USD MILLION) 219
TABLE 270 CHINA: NIPT MARKET, BY METHOD, 2024–2029 (USD MILLION) 219
TABLE 271 CHINA: NIPT MARKET, BY APPLICATION, 2021–2023 (USD MILLION) 219
TABLE 272 CHINA: NIPT MARKET, BY APPLICATION, 2024–2029 (USD MILLION) 220
TABLE 273 CHINA: NIPT MARKET, BY END USER, 2021–2023 (USD MILLION) 220
TABLE 274 CHINA: NIPT MARKET, BY END USER, 2024–2029 (USD MILLION) 220
TABLE 275 INDIA: KEY MACROINDICATORS 221
TABLE 276 INDIA: NIPT MARKET, BY PRODUCT & SERVICE, 2021–2023 (USD MILLION) 221
TABLE 277 INDIA: NIPT MARKET, BY PRODUCT & SERVICE, 2024–2029 (USD MILLION) 222
TABLE 278 INDIA: NIPT PRODUCTS MARKET, BY TYPE, 2021–2023 (USD MILLION) 222
TABLE 279 INDIA: NIPT PRODUCTS MARKET, BY TYPE, 2024–2029 (USD MILLION) 222
TABLE 280 INDIA: NIPT CONSUMABLES MARKET, BY TYPE, 2021–2023 (USD MILLION) 223
TABLE 281 INDIA: NIPT CONSUMABLES MARKET, BY TYPE, 2024–2029 (USD MILLION) 223
TABLE 282 INDIA: NIPT INSTRUMENTS MARKET, BY TYPE, 2021–2023 (USD MILLION) 223
TABLE 283 INDIA: NIPT INSTRUMENTS MARKET, BY TYPE, 2024–2029 (USD MILLION) 224
TABLE 284 INDIA: NIPT MARKET, BY METHOD, 2021–2023 (USD MILLION) 224
TABLE 285 INDIA: NIPT MARKET, BY METHOD, 2024–2029 (USD MILLION) 224
TABLE 286 INDIA: NIPT MARKET, BY APPLICATION, 2021–2023 (USD MILLION) 225
TABLE 287 INDIA: NIPT MARKET, BY APPLICATION, 2024–2029 (USD MILLION) 225
TABLE 288 INDIA: NIPT MARKET, BY END USER, 2021–2023 (USD MILLION) 225
TABLE 289 INDIA: NIPT MARKET, BY END USER, 2024–2029 (USD MILLION) 226
TABLE 290 AUSTRALIA: KEY MACROINDICATORS 226
TABLE 291 AUSTRALIA: NIPT MARKET, BY PRODUCT & SERVICE, 2021–2023 (USD MILLION) 227
TABLE 292 AUSTRALIA: NIPT MARKET, BY PRODUCT & SERVICE, 2024–2029 (USD MILLION) 227
TABLE 293 AUSTRALIA: NIPT PRODUCTS MARKET, BY TYPE, 2021–2023 (USD MILLION) 227
TABLE 294 AUSTRALIA: NIPT PRODUCTS MARKET, BY TYPE, 2024–2029 (USD MILLION) 228
TABLE 295 AUSTRALIA: NIPT CONSUMABLES MARKET, BY TYPE, 2021–2023 (USD MILLION) 228
TABLE 296 AUSTRALIA: NIPT CONSUMABLES MARKET, BY TYPE, 2024–2029 (USD MILLION) 228
TABLE 297 AUSTRALIA: NIPT INSTRUMENTS MARKET, BY TYPE, 2021–2023 (USD MILLION) 229
TABLE 298 AUSTRALIA: NIPT INSTRUMENTS MARKET, BY TYPE, 2024–2029 (USD MILLION) 229
TABLE 299 AUSTRALIA: NIPT MARKET, BY METHOD, 2021–2023 (USD MILLION) 229
TABLE 300 AUSTRALIA: NIPT MARKET, BY METHOD, 2024–2029 (USD MILLION) 230
TABLE 301 AUSTRALIA: NIPT MARKET, BY APPLICATION, 2021–2023 (USD MILLION) 230
TABLE 302 AUSTRALIA: NIPT MARKET, BY APPLICATION, 2024–2029 (USD MILLION) 230
TABLE 303 AUSTRALIA: NIPT MARKET, BY END USER, 2021–2023 (USD MILLION) 231
TABLE 304 AUSTRALIA: NIPT MARKET, BY END USER, 2024–2029 (USD MILLION) 231
TABLE 305 SOUTH KOREA: KEY MACROINDICATORS 232
TABLE 306 SOUTH KOREA: NIPT MARKET, BY PRODUCT & SERVICE 2021–2023 (USD MILLION) 232
TABLE 307 SOUTH KOREA: NIPT MARKET, BY PRODUCT & SERVICE 2024–2029 (USD MILLION) 232
TABLE 308 SOUTH KOREA: NIPT PRODUCTS MARKET, BY TYPE, 2021–2023 (USD MILLION) 233
TABLE 309 SOUTH KOREA: NIPT PRODUCTS MARKET, BY TYPE, 2024–2029 (USD MILLION) 233
TABLE 310 SOUTH KOREA: NIPT CONSUMABLES MARKET BY TYPE, 2021–2023 (USD MILLION) 233
TABLE 311 SOUTH KOREA: NIPT CONSUMABLES MARKET BY TYPE, 2024–2029 (USD MILLION) 234
TABLE 312 SOUTH KOREA: NIPT INSTRUMENTS MARKET BY TYPE, 2021–2023 (USD MILLION) 234
TABLE 313 SOUTH KOREA: NIPT INSTRUMENTS MARKET BY TYPE, 2024–2029 (USD MILLION) 234
TABLE 314 SOUTH KOREA: NIPT MARKET, BY METHOD, 2021–2023 (USD MILLION) 235
TABLE 315 SOUTH KOREA: NIPT MARKET, BY METHOD, 2024–2029 (USD MILLION) 235
TABLE 316 SOUTH KOREA: NIPT MARKET, BY APPLICATION, 2021–2023 (USD MILLION) 235
TABLE 317 SOUTH KOREA: NIPT MARKET, BY APPLICATION, 2024–2029 (USD MILLION) 236
TABLE 318 SOUTH KOREA: NIPT MARKET, BY END USER, 2021–2023 (USD MILLION) 236
TABLE 319 SOUTH KOREA: NIPT MARKET, BY END USER, 2024–2029 (USD MILLION) 236
TABLE 320 REST OF ASIA PACIFIC: NIPT MARKET, BY PRODUCT & SERVICE 2021–2023 (USD MILLION) 237
TABLE 321 REST OF ASIA PACIFIC: NIPT MARKET, BY PRODUCT & SERVICE 2024–2029 (USD MILLION) 237
TABLE 322 REST OF ASIA PACIFIC: NIPT PRODUCTS MARKET, BY TYPE 2021–2023 (USD MILLION) 238
TABLE 323 REST OF ASIA PACIFIC: NIPT PRODUCTS MARKET, BY TYPE 2024–2029 (USD MILLION) 238
TABLE 324 REST OF ASIA PACIFIC: NIPT CONSUMABLES MARKET BY TYPE, 2021–2023 (USD MILLION) 238
TABLE 325 REST OF ASIA PACIFIC: NIPT CONSUMABLES MARKET BY TYPE, 2024–2029 (USD MILLION) 239
TABLE 326 REST OF ASIA PACIFIC: NIPT INSTRUMENTS MARKET BY TYPE, 2021–2023 (USD MILLION) 239
TABLE 327 REST OF ASIA PACIFIC: NIPT INSTRUMENTS MARKET BY TYPE, 2024–2029 (USD MILLION) 239
TABLE 328 REST OF ASIA PACIFIC: NIPT MARKET, BY METHOD, 2021–2023 (USD MILLION) 240
TABLE 329 REST OF ASIA PACIFIC: NIPT MARKET, BY METHOD, 2024–2029 (USD MILLION) 240
TABLE 330 REST OF ASIA PACIFIC: NIPT MARKET, BY APPLICATION 2021–2023 (USD MILLION) 240
TABLE 331 REST OF ASIA PACIFIC: NIPT MARKET, BY APPLICATION 2024–2029 (USD MILLION) 241
TABLE 332 REST OF ASIA PACIFIC: NIPT MARKET, BY END USER, 2021–2023 (USD MILLION) 241
TABLE 333 REST OF ASIA PACIFIC: NIPT MARKET, BY END USER, 2024–2029 (USD MILLION) 241
TABLE 334 LATIN AMERICA: NIPT MARKET, BY COUNTRY, 2021–2023 (USD MILLION) 242
TABLE 335 LATIN AMERICA: NIPT MARKET, BY COUNTRY, 2024–2029 (USD MILLION) 243
TABLE 336 LATIN AMERICA: NIPT MARKET, BY PRODUCT & SERVICE 2021–2023 (USD MILLION) 243
TABLE 337 LATIN AMERICA: NIPT MARKET, BY PRODUCT & SERVICE 2024–2029 (USD MILLION) 243
TABLE 338 LATIN AMERICA: NIPT PRODUCTS MARKET, BY TYPE, 2021–2023 (USD MILLION) 244
TABLE 339 LATIN AMERICA: NIPT PRODUCTS MARKET, BY TYPE, 2024–2029 (USD MILLION) 244
TABLE 340 LATIN AMERICA: NIPT CONSUMABLES